Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Acute Upper Respiratory Tract Infections
Interventions
DRUG

Ergoferon

Safety and Efficiency of liquid dosage form

DRUG

Placebo

Safety and Efficiency of liquid dosage form

Trial Locations (11)

119992

"State Educational Institution of Higher Professional Education Moscow State Medical Academy named after I.M. Sechenov", Moscow

150000

"State Budgetary Educational Institution of Higher Professional Education Yaroslavl State Medical Academy of Ministry of Health", Yaroslavl

191144

"State Budgetary Health Care Institution Сity Child Health Polyclinic №44", Saint Petersburg

192212

"St. Petersburg State Budgetary Health Care Institution Сity Polyclinic №44", Saint Petersburg

193312

"St. Peterburg State Health Care Institution Child Health City Hospital №45 of the Nevsky Region", Saint Peterburg

194100

"State Budgetary Educational Institution of Higher Professional Education St. Petersburg State Pediatric Medical Academy of Ministry of Health of Russian Federation", Saint Petersburg

194356

"Limited Liability Company Alliance Biomedical-Russian group", Saint Petersburg

196650

"State Health Care Institution Child Health City Hospital №22", Saint Petersburg

614066

"Municipal Health Care Institution City Child Health Clinical Polyclinic №5", Perm

620028

"Municipal Institution Child Health City Hospital №11", Yekaterinburg

630091

State Budgetary Educational Institution of Higher Professional Education Novosibirsk State Medical University of Ministry of Health of Russian Federation, Novosibirsk

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT01843842 - Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children | Biotech Hunter | Biotech Hunter